HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avon Cellu-Sculpt 60% Cellulite Reduction Claim Discontinued On NAD Review

This article was originally published in The Rose Sheet

Executive Summary

Avon has discontinued a claim used in print and broadcast ads for its Cellu-Sculpt Anti-Cellulite Slimming Treatment stating, "Visibly reduce cellulite by up to 60%. Improve firmness by over 60%." The company has decided to omit the statement from advertising following a review by the National Advertising Division of the Council for Better Business Bureaus
Advertisement

Related Content

NAD Takes Initiative In Reviews Of Anti-Aging, Cellulite Claims In 2004
NAD Takes Initiative In Reviews Of Anti-Aging, Cellulite Claims In 2004
FDA Draws The Line On Wrinkle Reduction Claims In Warning Letter
FDA Draws The Line On Wrinkle Reduction Claims In Warning Letter
Neutrogena Should Tailor Anti-Cellulite Ad Ingredient Claims – NAD
Neutrogena Should Tailor Anti-Cellulite Ad Ingredient Claims – NAD
Avon Solutions Cellu-Sculpt Marketed As Slimming Treatment
Avon Solutions Cellu-Sculpt Marketed As Slimming Treatment
Advertisement
UsernamePublicRestriction

Register

RS011815

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel